Regulatory Compliance
WCG Clinical | Insights
FDA’s Single IRB Requirement, Expected but Not Guaranteed in 2025
Blog Posts
WCG Clinical | Insights
Decentralized Trials: Thoughts for Sponsors, Investigators, and IRBs
Blog Posts
WCG Clinical | Insights
Compounded Drugs in Research: Navigating IND Exemptions and Current Regulations
Blog Posts
WCG Clinical | Insights
Answering FAQs on HIPAA & PHI: Protect Participants’ Privacy & Ensure Compliance
Blog Posts
WCG Clinical | Insights
The Upcoming sIRB Mandate and the Critical Role of Site Selection: Your Questions Answered
Blog Posts
WCG Clinical | Insights
Preparing Updates to IRB and Recruitment Processes for the Upcoming FDA DEI Mandate
Blog Posts
WCG Clinical | Insights
Unpacking the FDA’s Guidance on Developing Drugs for Treatment in Pediatric Inflammatory Bowel Disease
Blog Posts
WCG Clinical | Insights
Cancer Clinical Trial Eligibility Criteria: Washout Periods and Concomitant Medications Guidance for Industry, IRBs, and Clinical Investigators
Blog Posts
WCG Clinical | Insights
Cancer Clinical Trial Eligibility Criteria: Performance Status Guidance for Industry, IRB, and Clinical Investigators
Blog Posts
WCG Clinical | Insights